Associate, Asset Acquisition, GondolaBio
GondolaBio, Palo Alto, California, United States, 94306
About GondolaBio
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation. BridgeBio is a commercial-stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines, bridging academic advancements with meaningful patient outcomes. Founded in 2015, the company has a portfolio of 22+ drug development programs across multiple therapeutic areas, with three approved drugs and offices in the U.S. and internationally. Who You Are
GondolaBio’s Asset Acquisition team is seeking an Associate to help define our new programs. We are looking for ambitious scientists who’d like to contribute at the intersection of science and business. The team is responsible for finding, evaluating, and determining which therapeutic ideas GondolaBio will pursue, with emphasis on evaluating the scientific rationale behind therapeutic strategies. The team works closely with GondolaBio’s Investment Committee, composed of veteran drug developers and renowned academic scientists. Across the BridgeBio ecosystem, we have spearheaded partnerships to create, fund, and operate more than 30 new drug development programs. As a key member of the team, this position will help set the culture and business development of the company and will be the face of the organization. Responsibilities
Identify promising new preclinical or early clinical stage programs to treat genetically driven diseases through deep engagement with the literature, academic and industry experts, and internal development efforts Deeply evaluate all aspects of a potential therapeutic program—from genetic rationale and pre-clinical evidence to development plan and clinical trial design Advocate for programs that fit our goal of targeting the genetic source of disease by building a scientific and business case for each potential investment Interface with leading academics, patient advocacy groups, biotechs, and entrepreneurs Lead internal discussions with management and the Investment Committee Establish a focused investment strategy and follow through to identify new opportunities Coordinate and work with internal subject-matter experts to dive deeply for each project Education And Experience & Skills Requirements
You hold an advanced technical degree (PhD, MD, or MD+PhD) in the life sciences and/or medicine, from a top-tier academic institution Postdoctoral or residency training is a strong plus You have a demonstrated record of scientific achievement evidenced by lead-author publications, grants, patents, scholarships, or awards Previous experience in management consulting or venture capital from a top-tier firm, with significant diligence experience, or a business development role in a biotech or life sciences startup Postdoctoral fellows and/or medical residents with demonstrated interest in biotechnology business Ability to thrive in an intense environment and manage ambiguity Strong data-driven decision-making and problem-solving abilities, and the capacity to chart a course independently Sense of urgency aligned with rapid drug development processes No Matter Your Role, Successful Team Members Are
Patient Champions who put patients first and uphold strict ethical standards Entrepreneurial Operators who drive practical solutions with an ownership mindset Truth Seekers who are detailed, rational, and humble problem solvers Individuals Who Inspire Excellence in themselves and those around them High-quality executors who deliver against goals and milestones with quality, precision, and speed What We Offer
Patient Days, where we hear directly from individuals living with the conditions we seek to impact A culture inspired by values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak An unyielding commitment to always putting patients first A decentralized model that empowers program teams and minimizes bureaucracy A place to own the vision for your program and your career path A collaborative, fast-paced, data-driven environment Access to learning and development resources Robust and competitive compensation and benefits (Base, Bonus, Equity, health, welfare, retirement) Flexible PTO and rapid career advancement for strong performers Potential to work on multiple BridgeBio Pharma programs over time Partnerships with leading institutions Commitment to Diversity, Equity & Inclusion The base pay range for this position is $130,000 to $170,000 per year. The actual compensation offered will be determined based on job-related factors, including experience, skills, qualifications, and location. A bonus plan and equity will also be offered.
#J-18808-Ljbffr
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation. BridgeBio is a commercial-stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines, bridging academic advancements with meaningful patient outcomes. Founded in 2015, the company has a portfolio of 22+ drug development programs across multiple therapeutic areas, with three approved drugs and offices in the U.S. and internationally. Who You Are
GondolaBio’s Asset Acquisition team is seeking an Associate to help define our new programs. We are looking for ambitious scientists who’d like to contribute at the intersection of science and business. The team is responsible for finding, evaluating, and determining which therapeutic ideas GondolaBio will pursue, with emphasis on evaluating the scientific rationale behind therapeutic strategies. The team works closely with GondolaBio’s Investment Committee, composed of veteran drug developers and renowned academic scientists. Across the BridgeBio ecosystem, we have spearheaded partnerships to create, fund, and operate more than 30 new drug development programs. As a key member of the team, this position will help set the culture and business development of the company and will be the face of the organization. Responsibilities
Identify promising new preclinical or early clinical stage programs to treat genetically driven diseases through deep engagement with the literature, academic and industry experts, and internal development efforts Deeply evaluate all aspects of a potential therapeutic program—from genetic rationale and pre-clinical evidence to development plan and clinical trial design Advocate for programs that fit our goal of targeting the genetic source of disease by building a scientific and business case for each potential investment Interface with leading academics, patient advocacy groups, biotechs, and entrepreneurs Lead internal discussions with management and the Investment Committee Establish a focused investment strategy and follow through to identify new opportunities Coordinate and work with internal subject-matter experts to dive deeply for each project Education And Experience & Skills Requirements
You hold an advanced technical degree (PhD, MD, or MD+PhD) in the life sciences and/or medicine, from a top-tier academic institution Postdoctoral or residency training is a strong plus You have a demonstrated record of scientific achievement evidenced by lead-author publications, grants, patents, scholarships, or awards Previous experience in management consulting or venture capital from a top-tier firm, with significant diligence experience, or a business development role in a biotech or life sciences startup Postdoctoral fellows and/or medical residents with demonstrated interest in biotechnology business Ability to thrive in an intense environment and manage ambiguity Strong data-driven decision-making and problem-solving abilities, and the capacity to chart a course independently Sense of urgency aligned with rapid drug development processes No Matter Your Role, Successful Team Members Are
Patient Champions who put patients first and uphold strict ethical standards Entrepreneurial Operators who drive practical solutions with an ownership mindset Truth Seekers who are detailed, rational, and humble problem solvers Individuals Who Inspire Excellence in themselves and those around them High-quality executors who deliver against goals and milestones with quality, precision, and speed What We Offer
Patient Days, where we hear directly from individuals living with the conditions we seek to impact A culture inspired by values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak An unyielding commitment to always putting patients first A decentralized model that empowers program teams and minimizes bureaucracy A place to own the vision for your program and your career path A collaborative, fast-paced, data-driven environment Access to learning and development resources Robust and competitive compensation and benefits (Base, Bonus, Equity, health, welfare, retirement) Flexible PTO and rapid career advancement for strong performers Potential to work on multiple BridgeBio Pharma programs over time Partnerships with leading institutions Commitment to Diversity, Equity & Inclusion The base pay range for this position is $130,000 to $170,000 per year. The actual compensation offered will be determined based on job-related factors, including experience, skills, qualifications, and location. A bonus plan and equity will also be offered.
#J-18808-Ljbffr